Market Summary
USD75.25+0.78
Market Closed1.05%
CL Stock Price
CL RSI Chart
CL Valuation
CL Price/Sales (Trailing)
CL Profitability
CL Fundamentals
CL Revenue
CL Earnings
Price Action
52 Week Range
67.4083.26
(Low)(High)
Last 7 days
4.3%
Last 30 days
2.7%
Last 90 days
-4.5%
Trailing 12 Months
0.4%
CL Financial Health
CL Investor Care
Peers (Alternatives to Colgate-Palmolive)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
PG | 349.4B | 80.3B | 7.19% | -2.65% | 24.47 | 4.35 | 2.47% | -1.59% |
CL | 62.8B | 18.0B | 2.66% | 0.39% | 35.21 | 3.5 | 3.13% | -17.59% |
KMB | 44.9B | 20.2B | 6.37% | 8.36% | 23.21 | 2.23 | 3.78% | 6.62% |
CLX | 19.1B | 7.1B | -0.64% | 13.42% | 43.84 | 2.7 | -0.21% | 76.11% |
CHD | 18.6B | 5.4B | 3.65% | -11.68% | 25.18 | 3.49 | 3.57% | -49.98% |
| MID-CAP | ||||||||
REYN | 5.7B | 3.8B | -0.98% | -3.65% | 22.12 | 1.49 | 7.34% | -20.37% |
ELF | 4.2B | 496.6M | 5.58% | 205.77% | 89.58 | 8.45 | 30.80% | 132.00% |
SPB | 2.6B | 3.1B | 0.27% | -27.87% | 61.77 | 0.85 | 2.30% | -66.19% |
ENR | 2.4B | 3.0B | -5.77% | 14.62% | -10.05 | 0.82 | -1.67% | -257.67% |
WDFC | 2.4B | 509.0M | 1.11% | -3.82% | 37.96 | 4.68 | 2.14% | -3.67% |
CENT | 2.1B | 3.3B | -0.32% | -10.09% | 15.73 | 0.64 | -2.01% | -13.17% |
| SMALL-CAP | ||||||||
REV | 214.9M | - | -40.09% | -62.17% | -0.3 | 0.1 | - | -56.86% |
NATR | 196.1M | 437.1M | -5.63% | -39.07% | 14.91 | 0.45 | 2.15% | -41.44% |
OBCI | 123.9M | 63.4M | 1.09% | 20.23% | 25.41 | 1.95 | 4.21% | -51.45% |
UG | 43.0M | 13.6M | -20.61% | -56.29% | 14.3 | 3.16 | 7.56% | -27.60% |
Financials for Colgate-Palmolive
| Income Statement (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Revenue | 1.3% | 17,967 | 17,741 | 17,700 | 17,476 | 17,421 |
| Cost Of Revenue | 2.8% | 7,719 | 7,508 | 7,392 | 7,166 | 7,046 |
| Gross Profit | 0.1% | 10,248 | 10,233 | 10,308 | 10,310 | 10,375 |
| S&GA Expenses | 0.5% | 6,565 | 6,530 | 6,532 | 6,443 | 6,407 |
| R&D Expenses | 4.2% | 320 | 307 | - | - | - |
| EBITDA | 0.2% | 3,377 | 3,371 | 3,676 | 3,837 | - |
| EBITDA Margin | -1.3% | 0.19* | 0.19* | 0.21* | 0.22* | - |
| Earnings Before Taxes | -6.7% | 2,660 | 2,852 | 2,813 | 2,925 | 3,087 |
| EBT Margin | -7.9% | 0.15* | 0.16* | 0.16* | 0.17* | - |
| Interest Expenses | 43.3% | 172 | 120 | - | - | - |
| Net Income | -7.4% | 1,785 | 1,928 | 1,944 | 2,044 | 2,166 |
| Net Income Margin | -8.6% | 0.10* | 0.11* | 0.11* | 0.12* | - |
| Free Cahsflow | -14.5% | 2,556 | 2,989 | 3,014 | 2,546 | - |
| Balance Sheet | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Assets | -3.4% | 15,731 | 16,288 | 15,711 | 15,723 | 15,040 |
| Current Assets | -3.1% | 5,113 | 5,278 | 5,160 | 4,989 | 4,397 |
| Cash Equivalents | -17.4% | 775 | 938 | 858 | 877 | 832 |
| Inventory | 0.0% | 2,074 | 2,073 | 2,012 | 1,924 | 1,692 |
| Net PPE | 4.5% | 4,307 | 4,123 | 3,765 | 3,752 | 3,730 |
| Goodwill | 701.9% | 3,352 | 418 | 3,238 | 3,292 | 3,284 |
| Liabilities | -2.0% | 14,925 | 15,235 | 15,153 | 14,995 | 14,069 |
| Current Liabilities | -10.9% | 4,004 | 4,492 | 4,395 | 4,566 | 4,051 |
| LT Debt, Current | 7.7% | 14.00 | 13.00 | 13.00 | 12.00 | 12.00 |
| LT Debt, Non Current | 6.4% | 8,741 | 8,219 | 7,957 | 7,588 | 7,194 |
| Shareholder's Equity | -35.5% | 401 | 622 | 168 | 321 | 609 |
| Retained Earnings | 0.0% | 24,573 | 24,566 | 24,342 | 24,149 | 24,350 |
| Additional Paid-In Capital | 0.8% | 3,546 | 3,518 | 3,402 | 3,355 | 3,269 |
| Accumulated Depreciation | -1.0% | 5,195 | 5,249 | 5,291 | 5,169 | - |
| Shares Outstanding | 0.1% | 835 | 834 | 838 | - | - |
| Minority Interest | -6.0% | 405 | 431 | 390 | 407 | 362 |
| Cashflow (Last 12 Months) | (In Millions) | |||||
|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
| Cashflow From Operations | -14.5% | 2,556 | 2,989 | 3,014 | 3,113 | 3,325 |
| Share Based Compensation | -6.0% | 125 | 133 | 122 | 126 | 135 |
| Cashflow From Investing | -2.8% | -1,601 | -1,558 | -785 | -591 | -592 |
| Cashflow From Financing | 31.6% | -952 | -1,392 | -2,275 | -2,644 | -2,774 |
| Buy Backs | 4.6% | 1,308 | 1,251 | 1,398 | 1,358 | 1,320 |
Risks for CL
What is the probability of a big loss on CL?
4.6%
Probability that Colgate-Palmolive stock will be more than 20% underwater in next one year
0%
Probability that Colgate-Palmolive stock will be more than 30% underwater in next one year.
0%
Probability that Colgate-Palmolive stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does CL drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Colgate-Palmolive was unfortunately bought at previous high price.
Drawdowns
Returns for CL
Cumulative Returns on CL
4.8%
10-Year Cumulative Returns
3.2%
7-Year Cumulative Returns
3.3%
5-Year Cumulative Returns
6.4%
3-Year Cumulative Returns
What are the long-term rolling returns for CL?
FIve years rolling returns for Colgate-Palmolive.
Annualized Returns
Which funds bought or sold CL recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-03-28 | Acrisure Capital Management, LLC | new | - | 1,176,180 | 1,176,180 | 1.30% |
2023-03-27 | Neo Ivy Capital Management | new | - | 353,000 | 353,000 | 0.24% |
2023-03-23 | ETF MANAGERS GROUP, LLC | new | - | 449,497 | 449,497 | 0.02% |
2023-03-23 | MetLife Investment Management, LLC | reduced | -1.72 | 1,742,350 | 18,772,400 | 0.15% |
2023-03-17 | American Portfolios Advisors | added | 0.48 | -239,361 | 1,768,010 | 0.07% |
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -1.16 | 133,411 | 1,375,410 | 0.04% |
2023-03-13 | Claro Advisors LLC | reduced | -1.49 | -41,459 | 1,279,540 | 0.42% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 2.07 | 15,926,100 | 125,909,000 | 0.14% |
2023-03-10 | MATHER GROUP, LLC. | added | 2.81 | 1,642,480 | 12,374,500 | 0.24% |
2023-03-08 | Capital Asset Advisory Services LLC | added | 46.67 | 345,790 | 880,790 | 0.07% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Colgate-Palmolive News
Schedule 13G FIlings of Colgate-Palmolive
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 09, 2023 | vanguard group inc | 9.62% | 80,375,011 | SC 13G/A | |
| Feb 06, 2023 | state street corp | 5.97% | 49,899,351 | SC 13G/A | |
| Feb 03, 2023 | blackrock inc. | 8.1% | 68,041,416 | SC 13G/A | |
| Feb 14, 2022 | state street corp | 5.89% | 49,608,335 | SC 13G/A | |
| Feb 09, 2022 | vanguard group inc | 9.11% | 76,746,614 | SC 13G/A | |
| Feb 01, 2022 | blackrock inc. | 7.7% | 65,218,485 | SC 13G/A | |
| Feb 12, 2021 | state street corp | 5.92% | 50,722,444 | SC 13G | |
| Feb 10, 2021 | vanguard group inc | 8.83% | 75,657,186 | SC 13G/A | |
| Jan 29, 2021 | blackrock inc. | 6.8% | 58,107,209 | SC 13G/A | |
| Feb 14, 2020 | state street corp | 6.57% | 56,280,269 | SC 13G |
CL Fair Value
Colgate-Palmolive fair value in different scenarios
The table shows the Fair Value estimates for Colgate-Palmolive for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
| Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
|---|---|---|---|---|---|
| Very Low Inflation | 26.40 -64.92% | 35.20 -53.22% | 40.13 -46.67% | 60.83 -19.16% | 76.79 2.05% |
| Current Inflation | 23.55 -68.70% | 27.24 -63.80% | 38.60 -48.70% | 54.84 -27.12% | 66.42 -11.73% |
| Very High Inflation | 22.24 -70.45% | 27.17 -63.89% | 30.05 -60.07% | 43.43 -42.29% | 53.79 -28.52% |
Historical Colgate-Palmolive Fair Value Estimates
Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price
Recent SEC filings of Colgate-Palmolive
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Mar 29, 2023 | ARS | ARS | |
| Mar 29, 2023 | DEF 14A | DEF 14A | |
| Mar 29, 2023 | DEFA14A | DEFA14A | |
| Mar 15, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 4 | Insider Trading | |
| Mar 01, 2023 | 424B2 | Prospectus Filed | |
| Mar 01, 2023 | 8-K | Current Report | |
| Feb 27, 2023 | 424B2 | Prospectus Filed | |
| Feb 27, 2023 | FWP | Prospectus Filed |
Latest Insider Trading transactions for CL
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-03-13 | Kooyman John W | sold | -146,209 | 71.6709 | -2,040 | chief of staff |
2023-02-27 | POLK MICHAEL B | sold | -408,494 | 73.4834 | -5,559 | - |
2023-02-27 | POLK MICHAEL B | acquired | 408,620 | 71.65 | 5,703 | - |
2023-02-27 | CAHILL JOHN T | sold | -421,075 | 73.8339 | -5,703 | - |
2023-02-27 | CAHILL JOHN T | acquired | 408,620 | 71.65 | 5,703 | - |
2023-02-21 | HARRIS C MARTIN | acquired | 408,620 | 71.65 | 5,703 | - |
2023-02-21 | HARRIS C MARTIN | sold | -423,447 | 74.2498 | -5,703 | - |
2023-02-17 | Massey Sally | sold | -73,904 | 73.2456 | -1,009 | chief human resources officer |
2023-02-17 | Kooyman John W | sold | -111,050 | 73.3004 | -1,515 | chief of staff |
2023-02-17 | Daniels Jennifer | sold | -360,832 | 73.31 | -4,922 | clo and secretary |
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
CL Income Statement
2022-12-31Consolidated Statements of Income - USD ($) $ in Millions | 12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
| Income Statement [Abstract] | |||
| Net sales | $ 17,967 | $ 17,421 | $ 16,471 |
| Cost of sales | 7,719 | 7,046 | 6,454 |
| Gross profit | 10,248 | 10,375 | 10,017 |
| Selling, general and administrative expenses | 6,565 | 6,407 | 6,019 |
| Other (income) expense, net | 69 | 65 | 113 |
| Goodwill and intangible assets impairment charges | 721 | 571 | 0 |
| Operating profit | 2,893 | 3,332 | 3,885 |
| Non-service related postretirement costs | 80 | 70 | 74 |
| Interest (income) expense, net | 153 | 175 | 164 |
| Income before income taxes | 2,660 | 3,087 | 3,647 |
| Provision for income taxes | 693 | 749 | 787 |
| Net income including noncontrolling interests | 1,967 | 2,338 | 2,860 |
| Less: Net income attributable to noncontrolling interests | 182 | 172 | 165 |
| Net income attributable to Colgate-Palmolive Company | $ 1,785 | $ 2,166 | $ 2,695 |
| Earnings per common share, basic (in dollars per share) | $ 2.13 | $ 2.56 | $ 3.15 |
| Earnings per common share, diluted (in dollars per share) | $ 2.13 | $ 2.55 | $ 3.14 |
CL Balance Sheet
2022-12-31Consolidated Balance Sheets - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
|---|---|---|
| Current Assets | ||
| Cash and cash equivalents | $ 775 | $ 832 |
| Receivables (net of allowances of $70 and $78, respectively) | 1,504 | 1,297 |
| Inventories | 2,074 | 1,692 |
| Other current assets | 760 | 576 |
| Total current assets | 5,113 | 4,397 |
| Property, plant and equipment, net | 4,307 | 3,730 |
| Goodwill | 3,352 | 3,284 |
| Other intangible assets, net | 1,920 | 2,462 |
| Deferred income taxes | 135 | 193 |
| Other assets | 904 | 974 |
| Total assets | 15,731 | 15,040 |
| Current Liabilities | ||
| Notes and loans payable | 11 | 39 |
| Current portion of long-term debt | 14 | 12 |
| Accounts payable | 1,551 | 1,479 |
| Accrued income taxes | 317 | 436 |
| Other accruals | 2,111 | 2,085 |
| Total current liabilities | 4,004 | 4,051 |
| Long-term debt | 8,741 | 7,194 |
| Deferred income taxes | 383 | 395 |
| Other liabilities | 1,797 | 2,429 |
| Total liabilities | 14,925 | 14,069 |
| Commitments and contingent liabilities | 0 | 0 |
| Shareholders’ Equity | ||
| Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued) | 1,466 | 1,466 |
| Additional paid-in capital | 3,546 | 3,269 |
| Retained earnings | 24,573 | 24,350 |
| Accumulated other comprehensive income (loss) | (4,055) | (4,386) |
| Unearned compensation | (1) | (1) |
| Treasury stock, at cost | (25,128) | (24,089) |
| Total Colgate-Palmolive Company shareholders’ equity | 401 | 609 |
| Noncontrolling interests | 405 | 362 |
| Total equity | 806 | 971 |
| Total liabilities and equity | $ 15,731 | $ 15,040 |